Medtronic India Pvt. Ltd
India is in the top 20 medical device markets worldwide and is the fourth-largest market for medical devices in Asia.
Medtronic India Pvt. Ltd. began operations in India in 1979. It is the wholly owned subsidiary of Medtronic Plc, an American–Irish medical devices company. The company has presence across India in cities such as Mumbai, Ahmedabad, Bangalore, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Pune and Vadodara. Its business is categorised into four segments, namely the Cardiac and Vascular Group (CVG), the Restorative Therapies Group (RTG), the Diabetes Group and the Minimally Invasive Therapies Group (MITG). The company has research and development (R&D) facilities in Bangalore and Hyderabad.
- The total revenue of its parent company, Medtronic, stood at US$ 7.7 billion in the third quarter of FY23.
- Has over 90,000 employees worldwide; employs more than 1,100 people in India.
- Has presence in over 150 countries.
- 76 manufacturing facilities worldwide.
| Year | Milestone |
|---|---|
| 2022 |
In March 2022, Medtronic India launched the MiniMed 780G system in India, which is a next generation closed loop insulin pump system for the treatment of type 1 diabetes in people between 7-80 years. |
| 2021 |
In September 2021, Medtronic India Pvt. Ltd. introduced a surgical robotics experience centre in Gurugram to help clinicians with robotic-assisted surgery technology. In September 2021, Medtronic India Private Limited collaborated with Sher-I-Kashmir Institute of Medical Sciences (SKIMS) to introduce a new surgical skills lab in Srinagar. In July 2021, Medtronic India Private Limited introduced the Percept PC Deep Brain Stimulation (DBS) system for movement disorders such as epilepsy and Parkinson’s. In June 2021, Medtronic India Private Limited announced the launch of Micra AV – a miniaturised, fully self-contained pacemaker that delivers advanced pacing technology to atrioventricular (AV) block patients via a minimally invasive approach. Launched TYRX Envelope, an absorbable, single-use, antibacterial envelope designed to stabilise a cardiac implantable electronic device (CIED) or implanted neurostimulator while releasing antimicrobial agents over a minimum of seven days. |
| 2020 |
Apollo Hospitals Group announced a partnership with India Medtronic to integrate artificial intelligence (AI) for advanced stroke management for the first time in India. The USFDA-approved AI platform for stroke diagnosis has been validated by clinical trials Launched the ‘Sonicision Curved Jaw Cordless Ultrasonic Dissection System’, an ultrasonic dissection device in India. Announced an investment worth Rs. 1,200 crore (US$ 163.2 million) to expand its R&D centre for a medical device software and engineering solutions facility in Hyderabad, Telangana. |
| 2019 |
Launched the Mazor Stealth edition, a fully integrated procedural solution for surgical planning, workflow, execution, and confirmation of spine surgeries in India. Launched the ‘VenaSeal Closure System’, a minimally invasive procedure that uses a proprietary medical adhesive to close the diseased vein in patients with chronic venous disease (CVD). |
| 2018 |
Company partnered with the Cardiological Society of India to increase awareness of sudden cardiac arrests. |
| 2016 |
Announced roll-out of low-cost hip and knee programme in India. |
| 2001 |
Expanded into diabetic care category. |
| 1999 |
Expanded into spinal care category. |
| 1983 |
Expanded into the neuro-simulation category. |
| 1977 |
Introduced prosthetic heart valve. |
| 1957 |
Created the first battery-operated external pacemaker. |
| 1949 |
Company founded as a medical equipment repair shop. |
Partners
